Literature DB >> 12188897

Structure, function, and activation of coagulation factor VII.

Charles Eigenbrot1.   

Abstract

Factor VII is the coagulation protease responsible for starting a cascade of proteolytic events that lead to thrombin generation, fibrin deposition, and platelet activation. As such, FVII has attracted wide interest as a target for clinical anti-coagulant applications. Commensurate with the critical importance of maintaining balance between thrombosis and hemostasis and its place at the beginning of the coagulation process, FVII is subject to a variety of biological and biochemical control mechanisms, among them allosteric influences exerted by cofactors, substrates, and inhibitors. Sites on FVIIa where allosteric influences are exerted and manifested have been identified and characterized in considerable detail. In recent years, a three-dimensional context for the interpretation of these results has become available from structural studies. New X-ray structures have augmented specific aspects of our understanding, in particular the X-ray structure of a fragment of the FVII zymogen. This review summarizes general allosteric behaviors of FVIIa and recapitulates structural findings since 1996, with particular emphasis on the recently determined zymogen structure.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12188897     DOI: 10.2174/1389203023380675

Source DB:  PubMed          Journal:  Curr Protein Pept Sci        ISSN: 1389-2037            Impact factor:   3.272


  8 in total

1.  Disulfide locked variants of factor VIIa with a restricted beta-strand conformation have enhanced enzymatic activity.

Authors:  Henry R Maun; Charles Eigenbrot; Helga Raab; David Arnott; Lilian Phu; Sherron Bullens; Robert A Lazarus
Journal:  Protein Sci       Date:  2005-05       Impact factor: 6.725

2.  Structural basis for complement factor I control and its disease-associated sequence polymorphisms.

Authors:  Pietro Roversi; Steven Johnson; Joseph J E Caesar; Florence McLean; Kirstin J Leath; Stefanos A Tsiftsoglou; B Paul Morgan; Claire L Harris; Robert B Sim; Susan M Lea
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-18       Impact factor: 11.205

3.  Proteomics Analysis in Japanese Medaka Oryzias latipes Exposed to Humic Acid Revealed Suppression of Innate Immunity and Coagulation Proteins.

Authors:  Victoria V Yurchenko; Alexey A Morozov; Bogdan A Kiriukhin
Journal:  Biology (Basel)       Date:  2022-04-29

4.  Molecular basis of factor IXa recognition by heparin-activated antithrombin revealed by a 1.7-A structure of the ternary complex.

Authors:  Daniel J D Johnson; Jonathan Langdown; James A Huntington
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

5.  Molecular dynamics simulations and functional characterization of the interactions of the PAR2 ectodomain with factor VIIa.

Authors:  Qing Zhang; Helle H Petersen; Henrik Ostergaard; Wolfram Ruf; Arthur J Olson
Journal:  Proteins       Date:  2009-11-15

6.  Recombinant epidermal growth factor-like domain-1 from coagulation factor VII functionalized iron oxide nanoparticles for targeted glioma magnetic resonance imaging.

Authors:  Heng Liu; Xiao Chen; Wei Xue; Chengchao Chu; Yu Liu; Haipeng Tong; Xuesong Du; Tian Xie; Gang Liu; Weiguo Zhang
Journal:  Int J Nanomedicine       Date:  2016-10-06

7.  Exactin: A specific inhibitor of Factor X activation by extrinsic tenase complex from the venom of Hemachatus haemachatus.

Authors:  Vallerinteavide Mavelli Girish; R Manjunatha Kini
Journal:  Sci Rep       Date:  2016-08-25       Impact factor: 4.379

Review 8.  Molecular Insights into Determinants of Translational Readthrough and Implications for Nonsense Suppression Approaches.

Authors:  Silvia Lombardi; Maria Francesca Testa; Mirko Pinotti; Alessio Branchini
Journal:  Int J Mol Sci       Date:  2020-12-11       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.